COVID-19相关肺部阿斯伯吉洛症的临床特征:一个多中心的回顾性研究

Yasheng Zhan1,2, Guojun He3, Cheng Zhong1,4

  • 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

PubMed
概括

与COVID-19相关的肺阿斯伯吉洛症 (CAPA) 在19.44%的ICU患者中发生,通常是那些患有潜在疾病和高剂量葡萄糖皮质激素使用的人. 通过Aspergillus培养和Galactomannan测试进行早期诊断对于高风险的COVID-19患者至关重要.